Prescription Required.
Is the active ingredient.
Treatment of schizophrenia in adults.
Treatment of manic or mixed episodes associated with bipolar I disorder in adults.
Treatment of major depressive episodes associated with bipolar I disorder in adults.
Cariquel 6mg Cap (Cariprazine) is a dopamine D3 and D2 receptor partial agonist. It works by modulating dopamine activity in the brain, which is believed to be involved in the pathophysiology of schizophrenia and bipolar disorder. The precise mechanism by which it improves symptoms is not fully understood but is thought to be related to its unique receptor binding profile.
Store at a controlled room temperature of 20°C to 25°C (68°F to 77°F). Protect from light and moisture. Keep out of reach of children.
The dosage should be determined by a healthcare professional and individualized based on the patient's response and tolerability.
Dosage typically starts low and is gradually increased as needed.
Cariprazine is available in tablet form for oral administration.
Follow your doctor's instructions carefully and do not change your dose without consulting them.
Somnolence (sleepiness)
Akathisia (restlessness)
Weight gain
Parkinsonism (movement disorder)
Dyskinesia (involuntary movements)
Nausea
Vomiting
Constipation
Dizziness
QT prolongation (a heart rhythm abnormality)
Alcohol should be avoided or consumed in moderation while taking cariprazine, as it may increase the risk of sedation and other side effects.
Avoid driving or operating heavy machinery until you know how cariprazine affects you, as it can cause drowsiness and dizziness.
Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. Cariprazine should only be used during pregnancy or breastfeeding if the potential benefits outweigh the risks.
Cariprazine is not approved for use in children.
Dosage adjustment may be necessary for patients with severe kidney impairment.
Dosage adjustment may be necessary for patients with severe liver impairment.
Consult your doctor or pharmacist for complete prescribing information and latest updates.
Please refer to the official drug monograph from the regulatory agency in your country.
